Beneficient Enters into $1.36 Million GP Primary Capital Transaction

Core Viewpoint - Beneficient has successfully closed a $1.36 million primary capital commitment for 8F Fund, LP, marking its first GP Primary transaction since the announcement of its Public Stockholder Enhancement Transactions, which is expected to enhance shareholder value and support investment strategies in alternative assets [1][2]. Group 1: Financial Transactions - The financing of$1.36 million was exchanged for shares of Beneficient's Resettable Convertible Preferred Stock, which can be converted into Class A common stock [1]. - This transaction is anticipated to increase the collateral for the Company's ExAlt loan portfolio by approximately $1.36 million in alternative asset interests [1]. - Following the Public Stockholder Enhancement Transactions, the Company expects an addition of approximately$450,000 to its tangible book value, totaling around $10.23 million attributable to stockholders [2]. Group 2: Strategic Objectives - Beneficient's GP Primary Commitment Program aims to provide primary capital solutions and financing anchor commitments to general partners, addressing a potential demand of up to$330 billion for primary commitments [3]. - The management emphasizes the importance of innovative capital solutions for holders and managers of alternative assets, aiming to enhance the value of collateral backing the ExAlt loan portfolio [2]. Group 3: Company Overview - Beneficient is focused on democratizing the global alternative asset investment market, providing solutions for mid-to-high net worth individuals and small-to-midsized institutions [6]. - The Company operates its proprietary online platform, AltAccess, which offers various exit options and capital solutions for alternative asset holders [6].